How DSOs Value Your Cleveland Dental Practice: EBITDA

September 23, 2026

Key Takeaways

A Cleveland dental practice valuation for a DSO sale follows five steps: normalize owner compensation, document add-backs, calculate adjusted EBITDA, apply a market multiple, and model deal structure.
Adjusted EBITDA is the earnings figure buyers apply a multiple to, and every documented add-back is multiplied by that multiple to determine enterprise value.
Owner compensation normalization is typically the largest swing factor, and the direction of the adjustment depends on whether the owner is paid above or below a market-rate replacement dentist.
DSO offers combine cash at close, rollover equity, and earnouts, so two offers with the same headline number can produce very different real proceeds.
McLerran & Associates builds a diligence-grade, CPA-led valuation up front and creates competition among vetted buyers so the agreed value is more likely to hold through diligence instead of getting re-traded.

How A Cleveland Dental Practice Is Valued For A DSO Sale

The valuation process follows a defined sequence, and each step builds on the last. A weakness at any stage can compress the final number or create leverage for a buyer to re-trade the deal during diligence.

Gather financials and practice-management reports. Three years of profit-and-loss statements, tax returns, year-to-date financials, and provider-level production data from your practice-management software form the foundation.
Normalize owner compensation. The owner’s pay is restated to what a market-rate replacement dentist would cost. This restatement isolates the practice’s transferable operating profit.
Identify and unpack add-backs. Discretionary, personal, and non-recurring expenses are documented and added back to reported earnings to reflect what the business actually generates under normalized conditions.
Calculate adjusted EBITDA. EBITDA, or earnings before interest, taxes, depreciation, and amortization, is the earnings base buyers use. Adjusted EBITDA is that figure after normalization and add-backs.
Apply the appropriate multiple range. A market multiple is applied to adjusted EBITDA to produce an enterprise value range. The multiple depends on practice-specific factors rather than a fixed table.
Model deal structure and real proceeds. Cash at close, rollover equity, and earnouts combine differently across offers. Modeling each structure shows what the headline number is likely to put in your pocket.

The EBITDA Build: From Collections To Adjusted EBITDA

The EBITDA build starts with your collections and works down to a normalized earnings figure a buyer can underwrite. The sequence runs as follows.

Collections represent gross revenue. This is the starting point; the valuation basis is adjusted EBITDA.
Operating expenses are subtracted to arrive at net income, which is what the practice reports after paying staff, rent, supplies, and all other costs.
Interest, taxes, depreciation, and amortization are added back to net income to reach reported EBITDA. These items are financing and accounting entries that vary by ownership structure and do not reflect the practice’s underlying operating performance.
Normalization adjustments and add-backs are then applied to reported EBITDA to reach adjusted EBITDA, the figure a buyer actually applies a multiple to.

The add-back categories that most commonly move the number in a Cleveland general practice include the following.

Owner compensation above a market-rate replacement dentist. If the owner pays themselves above what a hired associate would cost for the same clinical role, the excess is a legitimate add-back. This is typically the largest single adjustment.
Personal expenses run through the practice. Vehicles, personal travel, family phone plans, club memberships, and similar costs that benefit the owner personally rather than the business are added back when documented.
Discretionary and non-recurring expenses. One-time legal fees, severance, or unusual consulting costs that are not expected to repeat under new ownership can be added back when they are genuinely non-recurring. Buyers typically accept 70 to 90 percent of seller-proposed add-backs after quality-of-earnings diligence, and verbal explanations rarely survive that review.
One-time equipment or technology purchases. A large equipment purchase fully expensed in a single year may be added back if it is not a recurring capital need.
Above-market rent paid to an owner-affiliated entity. If the owner also owns the building and charges the practice above-market rent, the above-market portion is a defensible add-back. Market rent for dental practices typically runs 5–8% of collections, so the adjustment is measurable.
Non-cash items. Depreciation and amortization are already added back in the EBITDA calculation, and other non-cash charges may also be identified.

Every add-back must be defensible because the multiple magnifies both its value and its risk. In a seven-times deal, a $50,000 EBITDA dispute equals a $350,000 purchase price difference. A buyer’s quality-of-earnings team is specifically tasked with challenging every imperfectly documented adjustment, so an aggressive add-back that cannot be substantiated often gets stripped out during diligence, which is where deals frequently get re-traded.

At a 7x multiple, every $100,000 of accepted add-back equals $700,000 of additional purchase price. That math runs in both directions, so an undocumented add-back that disappears during diligence costs the seller that same multiple of value.

Find out what your Cleveland practice is really worth

Owner Compensation Normalization: The Largest Swing Factor

Among all the add-backs discussed above, owner compensation normalization is typically the single largest swing factor in a DSO valuation of a Cleveland practice. A buyer is purchasing the practice’s transferable operating profit rather than the owner’s personal income. To measure that profit accurately, the owner’s pay is restated to what it would cost to hire a dentist to perform the same clinical work.

The direction of this adjustment matters significantly. If the owner is paid above market for the role they will continue to perform after closing, a portion may be added back. If the owner is paid below market while working heavy clinical hours, the buyer may reduce EBITDA to reflect realistic replacement economics. An S-corporation owner who takes a low W-2 salary and large distributions is a common example of the latter, because the buyer will normalize compensation upward, which reduces adjusted EBITDA.

The right benchmark for a replacement salary depends on the practice’s size, specialty, and provider mix. Owner compensation is recast to a fair-market clinical wage, and this recast is where many practices leave money on the table. An independent, CPA-led analysis establishes a defensible benchmark before the buyer’s team sets one for you.

The 5x–9x Range And What Drives A Practice To The Top Or Bottom

DSO transactions for single-location and smaller multi-provider general dental practices generally fall within a broad range, commonly cited as roughly 5x to 9x adjusted EBITDA. The specific multiple is shaped by the practice’s own characteristics and the competitive dynamics among buyers. Specialty practices can earn a premium over general dentistry at comparable scale, though the size of that premium can vary. No published table can substitute for a valuation of your specific practice.

Where a practice lands in that range often comes down to how transferable its revenue and earnings are. The factors that can push a Cleveland practice toward the top or bottom include the following.

Scale and revenue durability. Larger practices with consistent, growing collections draw more buyer interest and tend to command higher multiples. Scale is a primary driver of where a dental practice lands on the multiple ladder, although clinical quality also matters.
Provider depth and associate retention. A practice where the owner personally produces the large majority of revenue carries key-person risk. Provider concentration is one of the clearest reasons a dental practice multiple compresses, and buyers price that risk by applying a lower multiple or shifting consideration into earnouts and holdbacks.
Hygiene retention and recurring revenue. A robust hygiene department signals recurring, provider-independent revenue. Buyers look for hygiene recall as the recurring revenue moat in dentistry that drives restorative diagnoses and predictable revenue.
Payer mix and Medicaid exposure. A commercial PPO-weighted payer mix supports the top of the range. Buyers, particularly private equity-backed groups, often apply valuation discounts to practices with significant Medicaid exposure.
Owner dependence. The less the practice depends on the selling dentist’s personal relationships and chairside production, the more transferable the revenue and the higher the achievable multiple.
Facility and equipment condition. Deferred equipment replacement or facility investment can inflate near-term EBITDA while signaling future capital needs that buyers will price in.
Growth trajectory. A practice with a consistent upward collections trend is easier for a buyer to underwrite than one with flat or declining revenue.

The multiple reflects the practice’s specific numbers and market, and a formal valuation quantifies those factors.

Deal-Structure Math: Why Two Offers With The Same Headline Number Differ

A DSO offer is rarely a single number. It is a combination of components that pay out at different times, under different conditions, and with different levels of certainty. Two offers with identical headline enterprise values can produce meaningfully different amounts of cash in your pocket.

The three primary components are the following.

Cash at close. This is the guaranteed portion paid at closing. Formal DSO acquisitions typically structure cash at close at 65% to 75% of headline value, though this varies by buyer type and practice profile.
Rollover equity. This is a retained ownership stake in the acquiring DSO or its holding company. Equity can be held at the joint-venture level or the holding-company level. At the joint-venture level, the seller retains an interest in a specific practice entity, typically with distributions and a higher floor but lower ceiling. At the holding-company level, the seller holds an interest in the broader platform, with no distributions but a higher potential ceiling if the DSO achieves a favorable exit. As much as 40% of a DSO deal can be paid in equity rather than cash, meaning the owner is effectively underwriting the DSO as an investment. That equity is illiquid until the DSO achieves a liquidity event, which can take five to ten years or more.
Earnouts. These are payments contingent on the practice meeting post-close performance targets, typically tied to EBITDA over a defined period. Earnouts can be punitive, where missing a target by a small margin forfeits the entire payment, or non-punitive, where pro-rata provisions allow a near-miss to still pay most of the earnout. A later earnout start date, which gives the practice time to integrate before measurement begins, is also a meaningful protection worth negotiating.

Much of a DSO deal’s proceeds are typically treated at long-term capital gains rates rather than ordinary income, particularly the portion allocated to goodwill, which can meaningfully affect after-tax proceeds. Earnout payments tied to continued employment are generally treated as ordinary income. Consult your tax advisor for guidance specific to your situation.

The practical implication is that comparing offers requires modeling each structure’s real proceeds over time. An offer with a higher headline number but a larger equity component and punitive earnout terms may net less guaranteed cash than a lower headline offer with a higher cash-at-close percentage.

Compare your DSO offer against the real market

Cleveland And Northeast Ohio Buyer Dynamics

Deal structure matters, and so does who is bidding. The Cleveland and Northeast Ohio dental market draws active, competitive interest from DSO and private-equity-backed buyers, but that interest concentrates around practices that clear a meaningful revenue threshold. In the Cleveland and Northeast Ohio dental market, practices generating $1.5 million or more in annual collections are generally the point at which multiple buyers compete aggressively, though this $1.5 million threshold reflects general dental M&A guidance rather than a Cleveland-specific benchmark. The Cleveland market is characterized by a diverse mix of buyers including recent graduates, local practitioners, and DSOs.

Ohio was identified as one of the states with the most DSO activity in the first quarter of 2026, based on a compiled list of more than 70 DSO affiliations, openings, and acquisitions nationwide during Q1. That activity spans both general dentistry and specialty practices, with out-of-state platforms actively building Ohio footprints alongside regional buyers already operating in the market.

Local market conditions shape achievable cash-at-close in ways that national averages do not capture. Provider supply, practice density, payer mix, and the presence of well-capitalized regional buyers who already have density in Northeast Ohio all affect how aggressively a given buyer will bid. A buyer with existing infrastructure in the Cleveland market may model higher post-close EBITDA than a national platform without local operating support, and that difference in their underwriting can translate directly into a higher offer.

McLerran & Associates’ Cleveland office, led by Justin Klingshim, works directly in this market with recent closings in Ohio. That local presence means the firm understands which buyers are active in Northeast Ohio, which are building toward density in specific submarkets, and how to position a Cleveland practice to attract competitive bids from the buyers for whom it is most strategically valuable.

McLerran & Associates team: McLerran is the nation's largest dental-specific sell-side M&A advisory and brokerage firms — *McLerran & Associates team: McLerran is the nation’s largest dental-specific sell-side M&A advisory and brokerage firms*

Why A Buyer’s Valuation And An Independent CPA-Led Valuation Diverge

A valuation prepared by a DSO, or offered for free as part of an initial conversation, often serves as an anchor for negotiation rather than a full analysis. It is typically built from assumptions that reflect the buyer’s underwriting model instead of the seller’s defensible earnings. A buyer spends $50,000 to $200,000 or more dissecting a practice during diligence while the average seller spends nothing defending it, and only about 15% of sellers avoid a post-LOI re-trade, generally those who ran a forensic audit first.

A CPA-led, diligence-grade valuation built from the practice’s own management software and financials operates differently. Every add-back is unpacked and documented before the deal goes to market, so the number is more likely to hold when the buyer’s quality-of-earnings team scrutinizes it. The seller enters the negotiation with an evidence-backed position rather than a hope.

The stakes are concrete. A seller who claims $1.1 million of adjusted EBITDA but documents only $800,000 loses $300,000 of EBITDA, which at a 6x multiple equals $1.8 million of enterprise value eliminated because the add-back could not be documented.

McLerran & Associates works to control the narrative around your EBITDA. The firm builds a diligence-grade valuation up front, with every add-back unpacked and documented, so the agreed value has a stronger chance of holding through diligence instead of getting re-traded. The firm focuses on selling practices rather than simply listing them.

*At McLerran & Associates, every engagement is built on an ironclad, CPA-led EBITDA analysis and practice valuation.*

How To Pressure-Test A DSO’s EBITDA Assumptions Before Signing An LOI

The letter of intent (LOI) is the point at which seller leverage drops sharply. Once signed, the buyer enters an exclusivity period and has every incentive to challenge the EBITDA figure. The time to pressure-test the buyer’s assumptions is before you sign. A sell-side advisor does this work on your behalf, and the checklist below illustrates what that review typically covers.

Reconcile the buyer’s EBITDA to your own financials line by line. The buyer’s adjusted EBITDA figure should tie back to your actual profit-and-loss statement. Any gap requires an explanation.
Identify every add-back the buyer accepted or rejected and ask why. Add-backs the buyer rejected may be defensible with documentation. Add-backs the buyer accepted may be vulnerable if the supporting records are incomplete.
Confirm the replacement-compensation assumption used. Ask what market salary the buyer used to normalize your compensation. If it is above or below a defensible benchmark, the EBITDA figure is likely wrong in a direction that matters.
Test whether the buyer’s revenue and margin assumptions match your trailing twelve months. Buyers sometimes apply forward-looking assumptions that are more conservative than your actual recent performance. Your trailing twelve months of production and collections data is often the most defensible baseline.
Ask what happens to the earnout if EBITDA misses by a small margin. A punitive earnout structure can eliminate a large portion of your proceeds for a near-miss. Pro-rata provisions and a later start date are protections worth negotiating before the LOI is signed.
Confirm whether the equity component is joint-venture-level or holding-company-level. These are structurally different investments with different risk profiles, liquidity timelines, and potential returns. The distinction should be clear before you commit.

Frequently Asked Questions

What Is The Average EBITDA For A Dental Practice?

EBITDA margins vary by practice size, specialty, and payer mix. A healthy general practice typically runs a 35–45% owner profit margin (pre-tax, including owner compensation). After normalizing to a market-rate clinical and management compensation, normalized EBITDA margins generally run in the range of 18–28% of collections. Margins at or above 20% tend to draw the strongest buyer interest, while margins below roughly 15% can lead buyers to discount or pass. These are directional benchmarks, and your specific numbers depend on your overhead structure, provider model, and payer mix.

What Is The Typical Rule Of Thumb For Valuing A Dental Practice?

Rules of thumb, such as a percentage of annual collections, serve as sanity checks rather than valuations. They say nothing about overhead or profit after a fair-market dentist salary, and two practices with identical collections can produce dramatically different adjusted EBITDA figures depending on their cost structures. DSO transactions are valued on a multiple of adjusted EBITDA, generally in the 5x–9x range for single-location and smaller multi-provider general practices, with the specific multiple driven by the practice’s individual characteristics. A collections-based rule of thumb cannot substitute for a CPA-led EBITDA analysis.

How Much Can I Sell My Cleveland Dental Practice For?

The answer depends on your specific numbers and market. Your achievable multiple is shaped by your adjusted EBITDA, scale, provider depth, payer mix, and owner dependence, which is exactly what a valuation quantifies. Cleveland and Northeast Ohio draw active buyer interest, particularly for practices generating $1.5 million or more in annual collections, and the presence of multiple competing buyers can push both price and terms meaningfully higher than a single-buyer negotiation. No advisor can responsibly state a specific multiple before reviewing your financials.

How Do Add-Backs Change Your DSO Valuation?

Add-backs increase the EBITDA base before the multiple is applied, so every documented add-back is multiplied by the deal multiple. As noted earlier, at a 7x multiple, each $100,000 of add-back adds $700,000 to purchase price. The reverse is equally true, so an undocumented add-back that a buyer’s quality-of-earnings team strips out during diligence removes that same multiple of value from your proceeds. This is why documentation matters as much as the add-back itself, because a legitimate adjustment that cannot be proven with invoices, payroll records, or bank statements is treated as if it does not exist.

Conclusion: Control The Narrative Around Your EBITDA

A buyer-set number is built to frame the negotiation in the buyer’s favor, and a valuation that is not defended can cost a Cleveland practice owner a meaningful share of proceeds before the deal ever closes.

McLerran & Associates is a dental-only, sell-side advisor and advocate that builds a diligence-grade, CPA-led valuation up front and creates competition among vetted buyers, so your number has a stronger chance of holding under scrutiny instead of getting re-traded. The firm’s approach is built on roughly 35 years in the dental transition market, approximately 2,000 successful practice sales, about $2 billion in closed transaction volume, and more than 10,000 practices evaluated. McLerran’s transaction rate runs approximately 85–90%, compared with an industry norm closer to 35–40%, and its typical DSO bid process generates around ten offers over roughly 45–60 days.

Talk to a dental-only sell-side advisor